2049.TW
Hiwin Technologies Corporation
TaiwanTWDEQUITY
Industrials
DELAYED
Last price
348.50
▼ 18.00 (4.91%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
366.50
Prev close
366.50
Day high
368.50
Day low
348.00
Volume
5.39M
Market cap
$123.47B
P/E (TTM)
52.88
52W range
180.50 – 426.00
Day trading desk
Gap from prior close
0.00%
Prior close 366.50
VWAP
353.09
-1.30% from price
Relative volume
1.06×
Normal
Session range
5.89%
348.00 – 368.50
Position in range
2%
Near session low
ATR (14D)
25.46
7.31% of price
Prior day high
392.00
PDH
Prior day low
364.00
PDL
Bid / ask spread
—
Quote not published
Session volume
4.97M
Avg 4.70M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-6.56%
-5.2%
1M
+9.23%
+5.5%
3M
-11.65%
-14.7%
6M
+49.15%
+38.1%
YTD
+79.90%
+67.6%
1Y
+61.57%
+41.6%
3Y
+57.92%
-16.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 2049.TW open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
60.03M
Total on file
Fundamentals
Market cap$123.47B
Enterprise value$123.65B
Revenue (TTM)$26.39B
Gross profit$8.08B
EBITDA$4.70B
Net income$2.33B
EPS (TTM)$6.60
Free cash flow$1.94B
Total cash$9.36B
Total debt$9.70B
Book value / share$110.92
Shares outstanding353.79M
Float262.75M
Short % of float—
Dividend yield0.57%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E52.88
Forward P/E30.76
PEG ratio3.35
Price / sales—
Price / book3.15
EV / revenue4.69
EV / EBITDA26.32
Gross margin30.61%
Operating margin13.77%
Profit margin8.85%
Return on equity5.87%
Return on assets2.71%
Debt / equity24.71
Current ratio2.26
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $24.26B | $24.39B | $24.63B | $29.31B | -0.5% |
| Operating revenue | $24.26B | $24.39B | $24.63B | $29.31B | -0.5% |
| Cost of revenue | $17.28B | $17.17B | $16.98B | $18.60B | +0.6% |
| Gross profit | $6.98B | $7.22B | $7.66B | $10.72B | -3.3% |
| Research & development | $1.02B | $963.36M | $943.46M | $1.13B | +6.4% |
| Selling, general & admin | $4.31B | $4.20B | $4.06B | $4.01B | +2.7% |
| Total operating expense | $5.33B | $5.16B | $5.00B | $5.14B | +3.4% |
| Operating income | $1.64B | $2.06B | $2.65B | $5.57B | -20.2% |
| Net interest income | -$128.50M | -$82.85M | -$132.42M | -$132.97M | -55.1% |
| Pre-tax income | $1.76B | $2.25B | $2.54B | $5.82B | -21.6% |
| Tax provision | $353.96M | $386.82M | $708.54M | $1.51B | -8.5% |
| Net income | $1.53B | $1.97B | $2.03B | $4.48B | -22.6% |
| Net income to common | $1.53B | $1.97B | $2.03B | $4.48B | -22.6% |
| Basic EPS | 4.31 | 5.57 | 5.75 | 12.98 | -22.6% |
| Diluted EPS | 4.30 | 5.56 | 5.74 | 12.89 | -22.7% |
| EBIT | $1.98B | $2.43B | $2.73B | $6.00B | -18.5% |
| EBITDA | $4.34B | $4.76B | $5.06B | $8.21B | -8.9% |
| Basic shares | 353.79M | 353.79M | 353.79M | 345.21M | 0.0% |
| Diluted shares | 354.46M | 354.37M | 354.71M | 347.47M | +0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $7.62B | $7.35B | $7.56B | $7.46B | +3.7% |
| Cash & short-term investments | $7.62B | $7.35B | $7.57B | $7.46B | +3.7% |
| Accounts receivable | $3.89B | $3.90B | $2.97B | $2.65B | -0.2% |
| Inventory | $7.09B | $7.41B | $7.49B | $8.94B | -4.2% |
| Total current assets | $19.86B | $19.98B | $19.23B | $20.32B | -0.6% |
| Property, plant & equipment | $31.72B | $31.43B | $29.88B | $29.45B | +0.9% |
| Goodwill & intangibles | $294.34M | $291.38M | $256.16M | $256.16M | +1.0% |
| Total assets | $54.18B | $54.43B | $51.44B | $52.14B | -0.5% |
| Total current liabilities | $8.53B | $8.32B | $7.96B | $9.41B | +2.5% |
| Current debt | $3.02B | $2.47B | $2.11B | $2.65B | +22.2% |
| Long-term debt | $6.71B | $7.56B | $6.95B | $6.31B | -11.2% |
| Total debt | $10.25B | $10.60B | $9.54B | $9.50B | -3.4% |
| Total liabilities | $16.70B | $17.36B | $16.32B | $17.17B | -3.8% |
| Retained earnings | $20.95B | $20.52B | $19.77B | $20.07B | +2.1% |
| Shareholder equity | $37.35B | $36.93B | $35.00B | $34.75B | +1.1% |
| Working capital | $11.33B | $11.66B | $11.27B | $10.91B | -2.8% |
| Net tangible assets | $37.05B | $36.64B | $34.74B | $34.50B | +1.1% |
| Shares issued | 353.79M | 353.79M | 353.79M | 353.79M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.76B | $2.25B | $2.54B | $5.82B | — | -21.6% |
| Depreciation & amortisation | $2.36B | $2.33B | $2.33B | $2.20B | — | +1.0% |
| Stock-based compensation | — | — | $0 | $18.27M | $0 | — |
| Change in working capital | $739.06M | -$352.88M | $1.06B | -$558.68M | — | +309.4% |
| Operating cash flow | $4.28B | $3.62B | $4.77B | $6.08B | — | +18.2% |
| Capital expenditure | -$2.77B | -$3.71B | -$2.94B | -$2.18B | — | +25.5% |
| Investing cash flow | -$2.82B | -$3.88B | -$2.85B | -$2.20B | — | +27.4% |
| Dividends paid | -$849.10M | -$884.48M | -$1.95B | -$1.53B | — | +4.0% |
| Financing cash flow | -$1.28B | -$18.95M | -$1.80B | -$1.92B | — | -6,643.4% |
| Free cash flow | $1.51B | -$95.79M | $1.83B | $3.90B | — | +1,677.8% |
| End cash position | $7.62B | $7.35B | $7.56B | $7.46B | — | +3.7% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $6.38B | $6.50B | $6.00B | $5.93B | $5.84B | -1.9% |
| Operating revenue | $6.38B | $6.50B | $6.00B | $5.93B | $5.84B | -1.9% |
| Cost of revenue | $4.34B | $4.74B | $4.28B | $4.16B | $4.10B | -8.5% |
| Gross profit | $2.04B | $1.76B | $1.71B | $1.76B | $1.74B | +15.9% |
| Research & development | $251.93M | $271.06M | $255.18M | $239.03M | $259.39M | -7.1% |
| Selling, general & admin | $1.16B | $1.17B | $1.05B | $1.02B | $1.06B | -1.5% |
| Total operating expense | $1.41B | $1.44B | $1.30B | $1.26B | $1.32B | -2.5% |
| Operating income | $630.52M | $315.36M | $410.55M | $498.57M | $418.75M | +99.9% |
| Net interest income | -$35.81M | -$39.65M | -$35.37M | -$20.03M | -$33.44M | +9.7% |
| Pre-tax income | $719.23M | $522.52M | $573.06M | $68.53M | $599.99M | +37.6% |
| Tax provision | $170.23M | $94.55M | $151.97M | -$34.68M | $142.13M | +80.0% |
| Net income | $579.34M | $461.98M | $445.85M | $135.24M | $482.80M | +25.4% |
| Net income to common | $579.34M | $461.98M | $445.85M | $135.24M | $482.80M | +25.4% |
| Basic EPS | 1.64 | — | 1.26 | 0.38 | 1.36 | — |
| Diluted EPS | 1.64 | — | 1.26 | 0.38 | 1.36 | — |
| EBIT | $773.65M | $587.58M | $625.19M | $118.31M | $648.27M | +31.7% |
| EBITDA | $1.40B | $1.19B | $1.21B | $702.35M | $1.23B | +17.5% |
| Basic shares | 353.79M | — | 353.85M | 355.88M | 353.79M | — |
| Diluted shares | 354.32M | — | 353.85M | 355.88M | 354.23M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.06B | $7.62B | $6.83B | $7.17B | $7.58B | +5.7% |
| Cash & short-term investments | $8.06B | $7.62B | $6.83B | $7.19B | $7.58B | +5.7% |
| Accounts receivable | $3.91B | $3.89B | $3.35B | $3.21B | $3.52B | +0.6% |
| Inventory | $7.24B | $7.09B | $7.54B | $7.39B | $7.54B | +2.1% |
| Total current assets | $20.34B | $19.86B | $19.06B | $19.13B | $19.89B | +2.4% |
| Property, plant & equipment | $31.51B | $31.72B | $31.46B | $31.33B | $31.72B | -0.6% |
| Goodwill & intangibles | $294.14M | $294.34M | $293.17M | $291.70M | $274.99M | -0.1% |
| Total assets | $54.79B | $54.18B | $53.26B | $53.29B | $54.32B | +1.1% |
| Total current liabilities | $8.87B | $8.53B | $8.25B | $8.83B | $9.10B | +3.9% |
| Current debt | $2.55B | $3.02B | $3.18B | $2.92B | $2.92B | -15.4% |
| Long-term debt | $6.79B | $6.71B | $6.63B | $6.77B | $7.10B | +1.1% |
| Total debt | $9.83B | $10.25B | $10.32B | $10.21B | $10.59B | -4.0% |
| Total liabilities | $17.14B | $16.70B | $16.38B | $17.09B | $17.73B | +2.6% |
| Retained earnings | $20.82B | $20.95B | $20.55B | $20.10B | $20.15B | -0.6% |
| Shareholder equity | $37.55B | $37.35B | $36.81B | $36.11B | $36.46B | +0.5% |
| Working capital | $11.48B | $11.33B | $10.81B | $10.30B | $10.79B | +1.3% |
| Net tangible assets | $37.26B | $37.05B | $36.52B | $35.82B | $36.19B | +0.6% |
| Shares issued | 353.79M | 353.79M | 353.79M | 353.79M | 353.79M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $719.23M | $522.52M | $573.06M | $68.53M | $599.99M | — | +37.6% |
| Depreciation & amortisation | $629.44M | $606.23M | $581.46M | $584.04M | $586.20M | — | +3.8% |
| Change in working capital | $98.60M | $638.10M | $148.21M | $31.09M | -$78.34M | — | -84.5% |
| Operating cash flow | $1.36B | $1.64B | $985.45M | $610.25M | $1.04B | — | -17.0% |
| Capital expenditure | -$453.65M | -$819.35M | -$621.96M | -$693.19M | -$631.30M | — | +44.6% |
| Investing cash flow | -$533.47M | -$833.61M | -$619.03M | -$691.87M | -$673.36M | — | +36.0% |
| Dividends paid | — | $0 | — | — | — | $0 | — |
| Financing cash flow | -$440.88M | -$140.63M | -$857.09M | -$47.94M | -$232.41M | — | -213.5% |
| Free cash flow | $906.79M | $820.13M | $363.49M | -$82.94M | $410.78M | — | +10.6% |
| End cash position | $8.06B | $7.62B | $6.83B | $7.17B | $7.58B | — | +5.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.21 | 2.39 | +8.0% |
| Mar 2026 | 1.26 | 1.64 | +30.4% |
| Dec 2025 | 1.25 | 1.30 | +4.1% |
| Sep 2025 | 1.58 | 1.26 | -20.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.90 | 9 | $8.03B | +34.0% |
| Next quarter | 2.69 | 9 | $8.03B | +23.5% |
| Current year | 9.49 | 14 | $29.90B | +23.3% |
| Next year | 11.34 | 16 | $33.45B | +11.9% |
Analyst targets & ownership
Mean target$398.71
High target$510.00
Low target$160.00
Implied upside14.41%
Analyst count17
ConsensusBUY
Strong buy / Buy3 / 9
Hold3
Sell / Strong sell1 / 1
Held by insiders17.00%
Held by institutions26.38%
Institutions holding88
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
371.05
-6.08% from price
SMA 20
349.48
-0.14% from price
SMA 50
337.08
+3.54% from price
SMA 100
330.43
+5.47% from price
SMA 200
273.01
+27.83% from price
EMA 12
361.89
-3.70% from price
EMA 26
351.55
-0.87% from price
EMA 50
342.24
+1.83% from price
RSI (14)
49.2
Neutral
MACD (12,26,9)
10.34
Hist -0.57
ATR (14)
25.46
7.30% of price
Realised vol 30D
68.7%
Annualised
Bollinger upper
414.52
20, 2σ
Bollinger lower
284.43
20, 2σ
50 / 200 cross
Golden
337.08 vs 273.01
Trend bias
Above 200
+27.83%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.27
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
68.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-30.9%
Peak to trough
Max drawdown 5Y
-53.0%
Peak to trough
ATR 14
25.46
7.30% of price
Beta (reported)
—
5Y monthly, from filing
Dividends & splits
Forward rate$2.00 / yr
Forward yield0.57%
5-year avg yield1.48%
Payout ratio36.44%
Ex-dividend dateJul 8, 2026
Next pay date—
Last split1030:1000
Split dateSep 16, 2021
Headlines
Novotech Strengthens Presence in Japan with Opening of Tokyo Office
Business Wire · 6m ago
Dow Jones Futures: Tariffs In Focus; Nvidia, Warsh Ahead
Investor's Business Daily · 12m ago
A Tax Strategy So Aggressive It Built the World’s Largest Hedge Fund and Made Losing Money the Hottest Product on Wall Street
24/7 Wall St. · 13m ago
Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside?
Insider Monkey · 14m ago
The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up.
Motley Fool · 17m ago
Prediction: Oklo Won't Book Its First Commercial Power Revenue Before 2028
Motley Fool · 21m ago
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
Insider Monkey · 24m ago
Syria says Israel talks addressed de-escalation, staying out of Israel-Turkey tensions
AFP · 30m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.